#intracerebral-hemorrhage

[ follow ]
#recombinant-factor-viia #clinical-trial #thromboembolic-risk #minimally-invasive-surgery
Medicine
fromNews Center
4 days ago

Experimental Stroke Drug Slows Bleeding but Doesn't Improve Recovery - News Center

Recombinant factor VIIa given within two hours of intracerebral hemorrhage reduced hematoma growth but did not improve 180-day functional recovery and increased thrombotic risk.
fromNews Center
4 months ago

Minimally Invasive Surgery May Improve Outcomes in Severe Stroke - News Center

This trial shows this procedure is safe, effective, generalizable and surgeons can offer it. It will certainly help in terms of getting patients out of the ICU faster,
Medicine
[ Load more ]